KBC Group NV Grows Position in Avantor, Inc. (NYSE:AVTR)


Share on StockTwits

KBC Group NV lifted its stake in shares of Avantor, Inc. (NYSE:AVTR) by 10.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 234,967 shares of the company’s stock after buying an additional 22,159 shares during the quarter. KBC Group NV’s holdings in Avantor were worth $6,798,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD raised its holdings in shares of Avantor by 30.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 67,163,849 shares of the company’s stock valued at $1,890,662,000 after buying an additional 15,742,336 shares during the period. BlackRock Inc. raised its holdings in shares of Avantor by 10.4% during the 4th quarter. BlackRock Inc. now owns 32,849,470 shares of the company’s stock valued at $924,713,000 after buying an additional 3,081,641 shares during the period. Viking Global Investors LP raised its holdings in shares of Avantor by 62.6% during the 4th quarter. Viking Global Investors LP now owns 13,358,729 shares of the company’s stock valued at $376,048,000 after buying an additional 5,141,022 shares during the period. Canada Pension Plan Investment Board raised its holdings in shares of Avantor by 825.7% during the 4th quarter. Canada Pension Plan Investment Board now owns 11,571,479 shares of the company’s stock valued at $325,737,000 after buying an additional 10,321,479 shares during the period. Finally, Norges Bank purchased a new stake in shares of Avantor during the 4th quarter valued at about $246,656,000. Institutional investors and hedge funds own 84.79% of the company’s stock.

Shares of AVTR opened at $31.27 on Tuesday. The firm has a market cap of $18.20 billion, a price-to-earnings ratio of 260.58, a PEG ratio of 1.07 and a beta of 1.84. The stock has a 50 day moving average of $30.66 and a 200-day moving average of $28.34. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 3.27. Avantor, Inc. has a 52 week low of $16.37 and a 52 week high of $33.99.

Avantor (NYSE:AVTR) last issued its earnings results on Tuesday, April 27th. The company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.28 by $0.07. Avantor had a return on equity of 44.58% and a net margin of 2.21%. The company had revenue of $1.79 billion during the quarter, compared to analyst estimates of $1.70 billion. During the same quarter last year, the firm earned $0.17 EPS. The business’s revenue was up 17.6% on a year-over-year basis. On average, sell-side analysts predict that Avantor, Inc. will post 0.85 earnings per share for the current fiscal year.

In related news, EVP Gerard Brophy sold 19,769 shares of the business’s stock in a transaction that occurred on Monday, February 22nd. The stock was sold at an average price of $28.62, for a total transaction of $565,788.78. Following the completion of the transaction, the executive vice president now owns 175,443 shares in the company, valued at approximately $5,021,178.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Devashish Ohri sold 100,160 shares of the business’s stock in a transaction on Monday, April 12th. The stock was sold at an average price of $32.37, for a total value of $3,242,179.20. Following the transaction, the executive vice president now owns 118,679 shares of the company’s stock, valued at approximately $3,841,639.23. The disclosure for this sale can be found here. Insiders have sold a total of 182,456 shares of company stock valued at $5,648,168 in the last 90 days. Insiders own 1.90% of the company’s stock.

Several equities research analysts recently commented on AVTR shares. JPMorgan Chase & Co. raised their target price on Avantor from $35.00 to $40.00 and gave the company an “overweight” rating in a report on Thursday, April 29th. Raymond James raised their target price on Avantor from $34.00 to $37.00 and gave the company an “outperform” rating in a report on Thursday, April 29th. KeyCorp lifted their price objective on Avantor from $33.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, January 19th. Barclays began coverage on Avantor in a report on Monday, March 8th. They set an “overweight” rating and a $33.00 price objective on the stock. Finally, Citigroup lifted their price objective on Avantor from $33.00 to $35.00 in a report on Thursday, February 4th. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Avantor currently has a consensus rating of “Buy” and a consensus target price of $35.00.

About Avantor

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits.

Read More: What Are Treasury Bonds?

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.